Bioperfectus Headquarters Welcomed Shanghai Consulate General of Pakistan

Company news

Bioperfectus headquarters is glad to have welcomed the first group of visitors from Pakistan on this Friday. Mr. Hussain Haider, the Consul General of Pakistan in Shanghai, accompanied by the Trade Commissioner, Ms. Shen Han and the administrative officers from Taizhou city together visited Bioperfectus exhibition hall.


Mr. Hussain Haider showed interest in Bioperfectus expertise in the infectious disease prevention and control and asked about how was Bioperfectus presence in Pakistan. Our regional manager, Cassie Bao told Mr. Hussain Haider that “Pakistan is one of the major markets for Bioperfectus in APAC region, we Bioperfectus are pleased to have made our humble contribution to the local COVID-19 prevention and control. Our COVID-19 Coronavirus Real Time PCR Kits are applied in the airport PCR test for international travel.’ Mr. Hussain highly appreciated Bioperfectus contribution in Pakistan and China’s assistance to Pakistan amid the COVID-19 pandemic.


On the eve of the 70anniversary of the establishment of diplomatic relationship between China and Pakistan, Bioperfectus are glad to have witnessed the significant development progress between two countries on molecular diagnostics and health care cooperation and we strongly believe that Sino-Pakistan friendship and cooperation will be further strengthened in the near future!


Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.


Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.


Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).